Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motilitone as add-on to Pantoprazole in LPRD
NCT02533349Phase 3Unknown
- Sponsor
- Samsung Medical Center
- Start
- May 2016
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
A Phase 3 trial of Motilitone in Laryngopharyngeal reflux disease (LPR), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
Motilitone
03
Conditions
Laryngopharyngeal reflux disease (LPR)
Beyond the preview
Go deeper on NCT02533349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02533349.